A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
about
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Phase II study of (153)Sm-ED ...... atients with multiple myeloma.
@en
A Phase II study of
@nl
type
label
A Phase II study of (153)Sm-ED ...... atients with multiple myeloma.
@en
A Phase II study of
@nl
prefLabel
A Phase II study of (153)Sm-ED ...... atients with multiple myeloma.
@en
A Phase II study of
@nl
P2093
P2860
P50
P356
P1476
A Phase II study of (153)Sm-ED ...... atients with multiple myeloma.
@en
P2093
David J Inwards
Dennis A Gastineau
Francis Buadi
Gregory A Wiseman
Ivana N Micallef
Jake Allred
Krista M Laumann
Luis Porrata
Mark R Litzow
Michelle A Elliott
P2860
P304
P356
10.1002/AJH.21696
P577
2010-06-01T00:00:00Z